glp 1 not working Outpatient Sedation Basics for Patients on GLP-1 Medications Why Is My GLP-1 Not

Shared decision-making between clinician and patient is essential when choosing between these agents

Several studies have identified an association between semaglutide use and a higher incidence of NAION, although researchers continue to examine the biological mechanisms involved and whether other patient-specific risk factors contribute to the condition

In addition, fewer Wegovy-treated patients experienced deterioration in NYHA functional class compared to those who were given placebo (2.09% versus 5.24%, respectively

On April 2, 2025, the Trump administration invoked the International Emergency Economic Powers Act (IEEPA) to enact a 10% baseline tariff across most imported goods, including pharmaceuticalsknown as the Liberation Day tariffs

Semaglutide (Ozempic, Wegovy) Semaglutide is another GLP-1 agonist that has been in the news lately due to its reported efficacy as a weight loss agent

Its main risk is renal stones, and most of its side effectscognitive problems, imbalance, and paresthesiasare dose related